Go Pro

Oracle (ORCL) Financials

Oracle logo
$144.44 -4.76 (-3.19%)
Closing price 09/23/2026 03:59 PM Eastern
Extended Trading
$137.88 -6.56 (-4.54%)
As of 09:17 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Oracle

Annual Income Statements for Oracle

This table shows Oracle's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 5/31/2016 5/31/2017 5/31/2018 5/31/2019 5/31/2020 5/31/2021 5/31/2022 5/31/2023 5/31/2024 5/31/2025 5/31/2026
Net Income / (Loss) Attributable to Common Shareholders
8,901 9,452 3,587 11,083 10,135 13,746 6,717 8,503 10,467 12,443 16,984
Consolidated Net Income / (Loss)
8,901 9,452 3,587 11,083 10,135 13,746 6,717 8,503 10,467 12,443 17,087
Net Income / (Loss) Continuing Operations
8,901 9,452 3,587 11,083 10,135 13,746 6,717 8,503 10,467 12,443 17,087
Total Pre-Tax Income
11,442 11,680 12,424 12,268 12,063 12,999 7,649 9,126 11,741 14,160 19,554
Total Operating Income
12,604 12,913 13,264 13,535 13,896 15,213 10,926 13,093 15,353 17,678 20,606
Total Gross Profit
29,568 30,340 31,323 34,364 33,946 35,154 36,255 41,151 52,070 56,617 66,489
Total Revenue
37,047 37,792 39,383 39,506 39,068 40,479 42,440 49,954 52,961 57,399 67,357
Operating Revenue
37,047 37,792 39,383 39,506 39,068 40,479 42,440 49,954 52,961 57,399 67,357
Total Cost of Revenue
7,479 7,452 8,060 5,142 5,122 5,325 6,185 8,803 891 782 868
Operating Cost of Revenue
7,479 7,452 8,060 5,142 5,122 5,325 6,185 8,803 891 782 868
Total Operating Expenses
16,964 17,427 18,059 20,829 20,050 19,941 25,329 28,058 36,717 38,939 45,883
Selling, General & Admin Expense
1,155 1,172 1,282 1,265 1,181 1,254 1,317 1,579 1,548 1,602 1,618
Marketing Expense
7,884 8,085 8,433 8,509 8,094 7,682 8,047 8,833 8,274 8,651 8,331
Research & Development Expense
5,787 6,153 6,084 6,026 6,067 6,527 7,219 8,623 8,915 9,860 10,272
Amortization Expense
1,638 1,451 1,620 1,689 1,586 1,379 1,150 3,582 3,010 2,307 1,671
Other Operating Expenses / (Income)
- - - 2,853 2,816 2,530 2,692 4,761 14,252 16,145 22,153
Restructuring Charge
500 566 640 487 306 569 4,904 680 718 374 1,838
Total Other Income / (Expense), net
-1,162 -1,233 -840 -1,267 -1,833 -2,214 -3,277 -3,967 -3,612 -3,518 -1,052
Interest Expense
1,467 1,798 2,025 2,082 1,995 2,496 2,755 3,505 3,514 3,578 4,599
Other Income / (Expense), net
305 565 1,185 815 162 282 -522 -462 -98 60 3,547
Income Tax Expense
2,541 2,228 8,837 1,185 1,928 -747 932 623 1,274 1,717 2,467
Preferred Stock Dividends Declared
- - - - - - - - 0.00 0.00 103
Basic Earnings per Share
$2.11 $2.30 $0.87 $3.05 $3.16 $4.67 $2.49 $3.15 $3.82 $4.46 $5.94
Weighted Average Basic Shares Outstanding
4.22B 4.12B 4.12B 3.63B 3.21B 2.95B 2.70B 2.70B 2.74B 2.79B 2.86B
Diluted Earnings per Share
$2.07 $2.24 $0.85 $2.97 $3.08 $4.55 $2.41 $3.07 $3.71 $4.34 $5.83
Weighted Average Diluted Shares Outstanding
4.31B 4.22B 4.24B 3.73B 3.29B 3.02B 2.79B 2.77B 2.82B 2.87B 2.91B
Weighted Average Basic & Diluted Shares Outstanding
4.12B 4.11B 4.12B 3.63B 3.07B 2.79B 2.66B 2.71B 2.76B 2.81B 2.88B
Cash Dividends to Common per Share
$0.60 $0.64 $0.76 $0.81 $0.96 $1.04 $1.28 $1.36 $1.60 $1.70 $2.00

Quarterly Income Statements for Oracle

This table shows Oracle's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 5/31/2025 8/31/2025 11/30/2025 2/28/2026 5/31/2026 8/31/2026
Total Costs & Expenses
- - - - - - 10,649 - - - 12,617
Net Income / (Loss) Attributable to Common Shareholders
2,401 3,143 2,929 3,151 2,936 3,427 2,927 6,135 3,699 4,223 4,679
Consolidated Net Income / (Loss)
2,401 3,143 2,929 3,151 2,936 3,427 2,927 6,135 3,721 4,304 4,760
Net Income / (Loss) Continuing Operations
2,401 3,143 2,929 3,151 2,936 3,427 2,927 6,135 3,721 4,304 4,760
Total Pre-Tax Income
2,865 3,781 3,169 3,390 3,448 4,153 3,427 6,342 4,416 5,369 5,607
Total Operating Income
3,750 4,685 3,991 4,220 4,358 5,109 4,277 4,731 5,464 6,134 6,728
Total Gross Profit
10,611 11,523 13,145 13,887 13,933 12,308 10,042 15,843 17,007 18,891 11,612
Total Revenue
13,280 14,287 13,307 14,059 14,130 15,903 14,926 16,058 17,190 19,183 19,345
Operating Revenue
13,280 14,287 13,307 14,059 14,130 15,903 14,926 16,058 17,190 19,183 19,345
Total Cost of Revenue
2,669 2,764 162 172 197 3,595 4,884 215 183 292 7,733
Operating Cost of Revenue
2,669 2,764 162 172 197 3,595 4,884 215 183 292 7,733
Total Operating Expenses
6,861 6,838 9,154 9,667 9,575 7,199 5,765 11,112 11,543 12,757 4,884
Selling, General & Admin Expense
377 403 358 387 390 467 376 409 389 444 376
Marketing Expense
2,042 2,113 2,036 2,190 2,119 2,306 2,063 2,149 2,052 2,067 1,811
Research & Development Expense
2,248 2,225 2,306 2,471 2,429 2,654 2,491 2,561 2,607 2,613 2,401
Amortization Expense
749 743 624 591 548 544 420 407 413 431 202
Restructuring Charge
245 194 86 115 91 82 415 427 173 823 94
Total Other Income / (Expense), net
-885 -904 -822 -830 -910 -956 -850 1,611 -1,048 -765 -1,121
Interest Expense
876 878 842 866 892 978 923 1,057 1,180 1,439 1,428
Other Income / (Expense), net
-9.00 -26 20 36 -18 22 73 2,668 132 674 307
Income Tax Expense
464 638 240 239 512 726 500 207 695 1,065 847
Preferred Stock Dividends Declared
- - - - 0.00 - 0.00 - 22 - 81
Basic Earnings per Share
$0.87 $1.15 $1.06 $1.13 $1.05 $1.22 $1.04 $2.14 $1.29 $1.47 $1.58
Weighted Average Basic Shares Outstanding
2.75B 2.74B 2.76B 2.79B 2.80B 2.79B 2.83B 2.86B 2.87B 2.86B 2.97B
Diluted Earnings per Share
$0.85 $1.11 $1.03 $1.10 $1.02 $1.19 $1.01 $2.10 $1.27 $1.45 $1.56
Weighted Average Diluted Shares Outstanding
2.82B 2.82B 2.85B 2.87B 2.87B 2.87B 2.91B 2.92B 2.91B 2.91B 3B
Weighted Average Basic & Diluted Shares Outstanding
2.75B 2.76B 2.77B 2.80B 2.80B 2.81B 2.84B 2.87B 2.88B 2.88B 3.02B

Annual Cash Flow Statements for Oracle

This table details how cash moves in and out of Oracle's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 5/31/2016 5/31/2017 5/31/2018 5/31/2019 5/31/2020 5/31/2021 5/31/2022 5/31/2023 5/31/2024 5/31/2025 5/31/2026
Net Change in Cash & Equivalents
-1,564 1,632 -164 -1,106 16,725 -7,141 -8,715 -11,618 689 332 20,503
Net Cash From Operating Activities
13,685 14,126 15,386 14,551 13,139 15,887 9,539 17,165 18,673 20,821 31,977
Net Cash From Continuing Operating Activities
13,685 14,126 15,386 14,551 13,139 15,887 9,539 17,165 18,673 20,821 31,977
Net Income / (Loss) Continuing Operations
8,901 9,452 3,587 11,083 10,135 13,746 6,717 8,503 10,467 12,443 17,087
Consolidated Net Income / (Loss)
8,901 9,452 3,587 11,083 10,135 13,746 6,717 8,503 10,467 12,443 17,087
Depreciation Expense
871 1,000 1,165 1,230 1,382 1,537 1,972 2,526 3,129 3,867 7,623
Amortization Expense
1,638 1,451 1,620 1,689 1,586 1,379 1,150 3,582 3,010 2,307 1,671
Non-Cash Adjustments To Reconcile Net Income
1,310 1,605 1,780 2,000 1,829 1,798 2,833 4,208 4,694 5,341 2,378
Changes in Operating Assets and Liabilities, net
965 618 7,270 -1,451 -1,793 -2,573 -3,133 -1,654 -2,627 -3,137 3,218
Net Cash From Investing Activities
-5,154 -21,494 -5,625 26,557 9,843 -13,098 11,220 -36,484 -7,360 -21,711 -51,854
Net Cash From Continuing Investing Activities
-5,154 -21,494 -5,625 26,557 9,843 -13,098 11,220 -36,484 -7,360 -21,711 -51,854
Purchase of Property, Plant & Equipment
-1,189 -2,021 -1,736 -1,660 -1,564 -2,135 -4,511 -8,695 -6,866 -21,215 -55,663
Acquisitions
-650 -11,221 -1,724 -363 -124 -41 -148 -27,721 0.00 0.00 0.00
Purchase of Investments
-24,562 -25,867 -25,282 -1,400 -5,731 -37,982 -10,272 -1,181 -1,066 -1,272 -2,039
Sale and/or Maturity of Investments
21,247 17,615 23,117 29,980 17,262 27,060 26,151 1,113 572 776 5,848
Net Cash From Financing Activities
-9,980 9,086 -9,982 -42,056 -6,132 -10,378 -29,126 7,910 -10,554 1,098 40,284
Net Cash From Continuing Financing Activities
-9,980 9,086 -9,982 -42,056 -6,132 -10,378 -29,126 7,910 -10,554 1,098 40,284
Repayment of Debt
-2,000 -4,352 -9,834 -4,636 -4,633 -2,435 -8,810 -21,105 -3,496 -16,171 -7,279
Repurchase of Common Equity
-10,440 -3,561 -11,347 -36,140 -19,240 -20,934 -16,248 -1,300 -1,202 -600 -95
Payment of Dividends
-2,626 -2,631 -3,140 -2,932 -3,070 -3,063 -3,457 -3,668 -4,391 -4,743 -5,787
Issuance of Debt
3,750 17,732 12,443 0.00 19,888 14,934 0.00 33,994 -167 21,437 43,808
Issuance of Preferred Equity
- - - - - - - - 0.00 0.00 4,954
Issuance of Common Equity
1,425 2,181 2,402 2,155 1,588 1,786 482 1,192 742 653 1,449
Other Financing Activities, net
-89 -283 -506 -503 -665 -666 -1,093 -1,203 -2,040 522 3,234
Effect of Exchange Rate Changes
-115 - - - - 448 -348 -209 -70 124 96
Cash Interest Paid
1,616 1,612 1,910 2,059 1,972 2,408 2,735 3,250 3,655 3,374 3,896
Cash Income Taxes Paid
2,331 1,983 1,562 2,901 3,218 3,189 2,567 3,009 3,560 4,020 3,704

Quarterly Cash Flow Statements for Oracle

This table details how cash moves in and out of Oracle's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 5/31/2025 8/31/2025 11/30/2025 2/28/2026 5/31/2026 8/31/2026
Net Change in Cash & Equivalents
1,237 973 162 325 6,465 -6,620 -1,336 8,796 19,214 -7,166 6,641
Net Cash From Operating Activities
5,475 6,081 7,427 1,304 5,933 6,157 8,140 2,066 7,151 14,620 23,103
Net Cash From Continuing Operating Activities
5,475 6,081 7,427 1,304 5,933 6,157 7,172 2,066 7,151 14,620 22,110
Net Income / (Loss) Continuing Operations
2,400 3,144 2,929 3,151 2,936 3,427 2,927 6,135 3,721 4,304 4,760
Consolidated Net Income / (Loss)
2,400 3,144 2,929 3,151 2,936 3,427 2,927 6,135 3,721 4,304 4,760
Depreciation Expense
808 811 804 908 1,003 1,152 1,351 1,704 2,153 2,415 3,156
Amortization Expense
749 743 624 591 548 544 420 406 413 432 202
Non-Cash Adjustments To Reconcile Net Income
1,349 1,136 1,137 1,488 1,322 1,545 320 -1,235 1,406 919 11,493
Changes in Operating Assets and Liabilities, net
169 247 1,933 -4,834 124 -511 2,154 -4,944 -542 6,550 2,499
Net Cash From Investing Activities
-1,783 -2,766 -2,765 -3,788 -5,976 -9,182 -8,718 -7,714 -19,544 -15,878 -28,580
Net Cash From Continuing Investing Activities
-1,783 -2,766 -2,765 -3,788 -5,976 -9,182 -8,718 -7,714 -19,544 -15,878 -28,580
Purchase of Property, Plant & Equipment
-1,674 -2,798 -2,303 -3,970 -5,862 -9,080 -8,502 -12,033 -18,635 -16,493 -28,499
Purchase of Investments
-159 -329 -477 -159 -202 -434 -471 -163 -1,029 -376 -306
Sale and/or Maturity of Investments
50 365 15 341 88 332 255 4,482 120 991 225
Net Cash From Financing Activities
-2,463 -2,274 -4,585 2,938 6,559 -3,814 210 14,487 31,498 -5,911 13,111
Net Cash From Continuing Financing Activities
-2,463 -2,274 -4,585 2,938 6,559 -3,814 210 14,487 31,498 -5,911 13,111
Repayment of Debt
-810 -966 -8,287 -1,689 -94 -4,679 470 -2,004 1,310 -7,150 -5,274
Repurchase of Common Equity
-450 -152 -150 -150 -150 -150 0.00 - - - 0.00
Payment of Dividends
-1,099 -1,102 -1,103 -1,118 -1,119 -1,403 -1,413 -1,435 -1,437 -1,502 -1,565
Issuance of Debt
- -167 5,627 5,814 7,711 2,285 0.00 17,880 26,664 -736 0.00
Issuance of Preferred Equity
- - - - - - 0.00 - - - 0.00
Issuance of Common Equity
28 288 179 128 213 133 1,153 138 9.00 132 19,950
Other Financing Activities, net
-132 -175 -851 -47 -2.00 - 0.00 -92 -2.00 3,345 0.00

Annual Balance Sheets for Oracle

This table presents Oracle's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 5/31/2016 5/31/2017 5/31/2018 5/31/2019 5/31/2020 5/31/2021 5/31/2022 5/31/2023 5/31/2024 5/31/2025 5/31/2026
Total Assets
112,180 134,991 137,851 108,709 115,438 131,107 109,297 134,384 140,976 168,361 261,759
Total Current Assets
64,313 74,515 76,159 46,386 52,140 55,567 31,633 21,004 22,554 24,579 46,567
Cash & Equivalents
20,152 21,784 21,620 20,514 37,239 30,098 21,383 9,765 10,454 10,786 31,289
Short-Term Investments
35,973 44,294 45,641 17,313 5,818 16,456 519 422 207 417 605
Accounts Receivable
5,385 5,300 5,136 5,134 5,551 5,409 5,953 6,915 7,874 8,558 10,385
Prepaid Expenses
2,591 3,137 3,762 3,425 3,532 3,604 3,778 3,902 4,019 4,818 4,288
Plant, Property, & Equipment, net
4,000 5,315 5,897 6,252 6,244 7,049 9,716 17,069 21,536 43,522 99,957
Total Noncurrent Assets
43,867 55,161 55,795 56,071 57,054 68,491 67,948 96,311 96,886 100,260 115,235
Goodwill
34,590 43,045 43,755 43,779 43,769 43,935 43,811 62,261 62,230 62,207 62,261
Intangible Assets
4,943 7,679 6,670 5,279 3,738 2,430 1,440 9,837 6,890 - 0.00
Noncurrent Deferred & Refundable Income Taxes
1,291 1,143 1,395 2,696 3,252 13,636 12,782 12,226 12,273 11,877 11,541
Other Noncurrent Operating Assets
3,043 3,294 3,975 4,317 6,295 8,490 9,915 11,987 15,493 26,176 41,433
Total Liabilities & Shareholders' Equity
112,180 134,991 137,851 108,709 115,438 131,107 109,297 134,384 140,976 168,361 261,759
Total Liabilities
64,390 80,745 90,978 86,346 102,721 125,155 115,065 132,828 131,737 147,392 218,703
Total Current Liabilities
17,208 24,178 19,124 18,630 17,200 24,164 19,511 23,090 31,544 32,643 41,764
Short-Term Debt
3,750 9,797 4,491 4,494 2,371 8,250 3,749 4,061 10,605 7,271 7,199
Accounts Payable
504 599 529 580 637 745 1,317 1,204 2,357 5,113 10,977
Current Deferred Revenue
7,655 8,233 8,341 8,374 8,002 8,775 8,357 8,970 9,313 9,387 9,916
Current Employee Benefit Liabilities
1,966 1,966 1,806 1,628 1,453 2,017 1,944 2,053 1,916 2,243 2,225
Other Current Liabilities
3,333 3,583 3,957 3,554 4,737 4,377 4,144 6,802 7,353 8,629 11,447
Total Noncurrent Liabilities
47,182 56,567 71,854 67,716 85,521 100,991 95,554 109,738 100,193 114,749 176,939
Long-Term Debt
40,105 48,112 56,128 51,673 69,226 75,995 72,110 86,420 76,264 85,297 122,342
Noncurrent Deferred Revenue
4,908 5,681 13,429 13,295 12,463 12,345 12,210 11,077 10,817 10,269 11,771
Noncurrent Deferred & Payable Income Tax Liabilities
- - - - 41 7,864 6,031 5,772 - - 0.00
Other Noncurrent Operating Liabilities
2,169 2,774 2,297 2,748 3,791 4,787 5,203 6,469 13,112 19,183 42,826
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
47,790 54,246 46,873 22,363 12,717 5,952 -5,768 1,556 9,239 20,969 43,056
Total Preferred & Common Equity
47,289 53,860 46,372 21,785 12,074 5,238 -6,220 1,073 8,704 20,451 42,508
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4,954
Total Common Equity
47,289 53,860 46,372 21,785 12,074 5,238 -6,220 1,073 8,704 20,451 37,554
Common Stock
24,217 27,065 28,950 26,909 26,486 26,533 26,808 30,215 32,764 37,107 43,243
Retained Earnings
23,888 27,598 19,111 -3,496 -12,696 -20,120 -31,336 -27,620 -22,628 -15,481 -4,309
Accumulated Other Comprehensive Income / (Loss)
-816 -803 -1,689 -1,628 -1,716 -1,175 -1,692 -1,522 -1,432 -1,175 -1,380
Noncontrolling Interest
501 386 501 578 643 714 452 483 535 518 548

Quarterly Balance Sheets for Oracle

This table presents Oracle's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026 Q1 2027
Period end date 8/31/2023 11/30/2023 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 8/31/2025 11/30/2025 2/28/2026 8/31/2026
Total Assets
136,662 134,324 137,082 140,976 144,214 148,483 161,378 180,449 204,984 245,240 303,259
Total Current Assets
22,166 19,289 21,063 22,554 23,072 23,503 30,116 24,634 34,366 54,874 55,630
Cash & Equivalents
11,613 8,244 9,481 10,454 10,616 10,941 17,406 10,445 19,241 38,455 36,369
Short-Term Investments
470 446 423 207 295 370 417 560 525 677 708
Accounts Receivable
6,519 6,804 7,297 7,874 8,021 8,177 8,051 8,843 9,440 10,719 11,394
Prepaid Expenses
3,564 3,795 3,862 4,019 4,140 4,015 4,242 4,786 5,160 5,023 7,159
Plant, Property, & Equipment, net
17,644 18,009 19,117 21,536 23,094 26,432 31,970 53,194 67,875 83,617 127,845
Total Noncurrent Assets
96,852 97,026 96,902 96,886 98,048 98,548 99,292 102,621 102,743 106,749 119,784
Goodwill
62,206 62,231 62,222 62,230 62,249 62,204 62,171 62,211 62,207 62,274 62,267
Intangible Assets
9,074 8,378 7,629 6,890 6,270 5,679 5,131 4,167 3,760 3,641 0.00
Noncurrent Deferred & Refundable Income Taxes
12,243 12,758 12,688 12,273 12,219 11,984 11,799 11,734 11,531 11,360 11,625
Other Noncurrent Operating Assets
13,329 13,659 14,363 15,493 17,310 18,681 20,191 24,509 25,245 29,474 45,892
Total Liabilities & Shareholders' Equity
136,662 134,324 137,082 140,976 144,214 148,483 161,378 180,449 204,984 245,240 303,259
Total Liabilities
133,821 129,946 130,900 131,737 132,945 134,247 144,117 155,783 174,527 206,189 236,063
Total Current Liabilities
25,357 24,407 24,885 31,544 32,045 29,052 29,623 39,874 37,795 40,737 47,514
Short-Term Debt
4,499 6,321 5,510 10,605 9,201 8,162 8,167 9,079 8,091 9,887 7,625
Accounts Payable
1,034 1,107 1,658 2,357 2,207 2,679 2,423 8,203 10,140 9,474 11,063
Current Deferred Revenue
11,120 8,878 8,931 9,313 11,455 9,430 9,019 12,098 9,940 9,881 14,686
Current Employee Benefit Liabilities
1,818 1,706 1,796 1,916 1,772 1,653 1,839 1,794 1,947 1,940 1,760
Other Current Liabilities
6,886 6,395 6,990 7,353 7,410 7,128 8,175 8,700 7,677 9,555 12,380
Total Noncurrent Liabilities
108,464 105,539 106,015 100,193 100,900 105,195 114,494 115,909 136,732 165,452 188,549
Long-Term Debt
84,442 82,468 82,470 76,264 75,314 80,462 88,109 82,236 99,984 124,718 117,712
Noncurrent Deferred Revenue
11,201 10,046 10,451 10,817 11,038 9,553 9,813 10,583 10,885 11,402 12,060
Noncurrent Deferred & Payable Income Tax Liabilities
5,281 5,244 4,483 3,692 3,442 2,864 2,208 0.00 0.00 0.00 0.00
Other Noncurrent Operating Liabilities
7,540 7,781 8,611 9,420 11,106 12,316 14,364 23,090 25,863 29,332 58,777
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,841 4,378 6,182 9,239 11,269 14,236 17,261 24,666 30,457 39,051 67,196
Total Preferred & Common Equity
2,370 3,866 5,623 8,704 10,816 13,746 16,730 24,154 29,951 38,495 66,772
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4,954 4,954
Total Common Equity
2,370 3,866 5,623 8,704 10,816 13,746 16,730 24,154 29,951 33,541 61,818
Common Stock
30,295 30,724 31,622 32,764 33,083 34,310 35,691 39,378 40,577 41,910 64,319
Retained Earnings
-26,428 -25,431 -24,533 -22,628 -20,939 -19,045 -17,368 -14,054 -9,355 -7,092 -1,114
Accumulated Other Comprehensive Income / (Loss)
-1,497 -1,427 -1,466 -1,432 -1,328 -1,519 -1,593 -1,170 -1,271 -1,277 -1,387
Noncontrolling Interest
471 512 559 535 453 490 531 512 506 556 424

Annual Metrics And Ratios for Oracle

This table displays calculated financial ratios and metrics derived from Oracle's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 5/31/2016 5/31/2017 5/31/2018 5/31/2019 5/31/2020 5/31/2021 5/31/2022 5/31/2023 5/31/2024 5/31/2025 5/31/2026
DEI Shares Outstanding
- - - - - - - - - - 2,876,046,000.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 2,876,046,000.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 5.91
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-3.08% 2.01% 4.21% 0.31% -1.11% 3.61% 4.84% 17.71% 6.02% 8.38% 17.35%
EBITDA Growth
-8.43% 3.31% 8.19% 0.20% -1.41% 8.13% -26.53% 38.54% 14.17% 11.77% 39.88%
EBIT Growth
-7.64% 4.41% 7.20% -0.69% -2.03% 10.22% -32.86% 21.41% 20.77% 16.28% 36.17%
NOPAT Growth
-8.71% 6.58% -63.35% 219.30% -4.52% 37.79% -40.36% 27.14% 12.20% 13.50% 15.91%
Net Income Growth
-10.43% 6.19% -62.05% 208.98% -8.55% 35.63% -51.13% 26.59% 23.10% 18.88% 37.32%
EPS Growth
-6.33% 8.21% -62.05% 249.41% 3.70% 47.73% -47.03% 27.39% 20.85% 16.98% 34.33%
Operating Cash Flow Growth
-6.14% 3.22% 8.92% -5.43% -9.70% 20.91% -39.96% 79.95% 8.79% 11.50% 53.58%
Free Cash Flow Firm Growth
61.89% -100.98% 9,125.76% 21.50% -5.40% 23.20% -63.15% -525.09% 147.01% -113.41% -1,405.47%
Invested Capital Growth
-3.18% 29.72% -12.69% 1.17% 1.36% 5.78% 10.42% 69.85% 4.39% 19.76% 37.49%
Revenue Q/Q Growth
-0.30% 0.97% 0.14% 0.31% -1.75% 1.98% 1.46% 4.16% 0.86% 2.90% 5.12%
EBITDA Q/Q Growth
-0.41% 2.89% 0.19% -0.07% -0.86% 3.42% -3.19% 2.68% 2.71% 2.64% 9.24%
EBIT Q/Q Growth
0.55% 2.36% 0.35% -0.44% -0.82% 3.87% -4.80% -2.06% 4.07% 2.73% 7.46%
NOPAT Q/Q Growth
0.23% 6.79% -2.70% 5.47% -4.11% 4.95% -5.33% 4.41% -3.86% 2.10% 4.03%
Net Income Q/Q Growth
0.66% 5.99% -1.99% 4.37% -5.80% 7.14% -11.16% 1.55% -1.64% 2.34% 5.41%
EPS Q/Q Growth
2.48% 6.67% 1.19% 8.00% -1.91% 9.11% -6.95% 0.99% -2.37% 1.88% 4.67%
Operating Cash Flow Q/Q Growth
-6.92% 5.00% 1.28% -1.61% -5.79% 8.38% -8.24% 10.72% 2.38% 0.37% 35.99%
Free Cash Flow Firm Q/Q Growth
-1.32% 39.74% -12.37% 20.46% -6.11% 5.76% -21.04% 5.17% -9.17% -135.98% 5.30%
Invested Capital Q/Q Growth
-0.43% 0.96% 4.41% 0.83% 1.37% 1.33% 2.94% 0.89% 1.41% 6.92% 4.59%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
79.81% 80.28% 79.53% 86.98% 86.89% 86.85% 85.43% 82.38% 80.52% 78.48% 98.71%
EBITDA Margin
41.62% 42.15% 43.76% 43.71% 43.58% 45.48% 31.87% 37.51% 40.40% 41.66% 49.66%
Operating Margin
34.02% 34.17% 33.68% 34.26% 35.57% 37.58% 25.74% 26.21% 28.99% 30.80% 30.59%
EBIT Margin
34.84% 35.66% 36.69% 36.32% 35.98% 38.28% 24.51% 25.29% 28.80% 30.90% 35.86%
Profit (Net Income) Margin
24.03% 25.01% 9.11% 28.05% 25.94% 33.96% 15.83% 17.02% 19.76% 21.68% 25.37%
Tax Burden Percent
77.79% 80.92% 28.87% 90.34% 84.02% 105.75% 87.82% 93.17% 89.15% 87.87% 87.38%
Interest Burden Percent
88.64% 86.66% 85.99% 85.49% 85.81% 83.89% 73.52% 72.25% 76.96% 79.83% 80.96%
Effective Tax Rate
22.21% 19.08% 71.13% 9.66% 15.98% -5.75% 12.18% 6.83% 10.85% 12.13% 12.62%
Return on Invested Capital (ROIC)
27.16% 25.61% 8.87% 30.22% 28.49% 37.90% 20.90% 18.76% 16.36% 16.55% 14.82%
ROIC Less NNEP Spread (ROIC-NNEP)
34.48% 35.38% 12.15% 10.65% 21.92% 30.83% 14.62% 13.26% 12.25% 12.62% 13.79%
Return on Net Nonoperating Assets (RNNOA)
-8.78% -7.09% -1.78% 1.80% 29.29% 109.36% 7,280.19% -422.51% 177.56% 65.84% 38.56%
Return on Equity (ROE)
18.37% 18.53% 7.09% 32.02% 57.78% 147.26% 7,301.09% -403.75% 193.92% 82.38% 53.38%
Cash Return on Invested Capital (CROIC)
30.39% -0.26% 22.42% 29.05% 27.14% 32.28% 11.00% -33.01% 12.06% -1.44% -16.76%
Operating Return on Assets (OROA)
11.57% 10.91% 10.59% 11.64% 12.54% 12.57% 8.66% 10.37% 11.08% 11.47% 11.23%
Return on Assets (ROA)
7.98% 7.65% 2.63% 8.99% 9.04% 11.15% 5.59% 6.98% 7.60% 8.04% 7.95%
Return on Common Equity (ROCE)
18.20% 18.37% 7.03% 31.52% 55.77% 136.56% -38,965.58% -493.38% 175.64% 79.51% 48.36%
Return on Equity Simple (ROE_SIMPLE)
18.82% 17.55% 7.74% 50.87% 83.94% 262.43% -107.99% 792.45% 120.26% 60.84% 0.00%
Net Operating Profit after Tax (NOPAT)
9,805 10,450 3,830 12,228 11,675 16,087 9,595 12,199 13,687 15,534 18,006
NOPAT Margin
26.47% 27.65% 9.72% 30.95% 29.88% 39.74% 22.61% 24.42% 25.84% 27.06% 26.73%
Net Nonoperating Expense Percent (NNEP)
-7.33% -9.76% -3.27% 19.57% 6.57% 7.07% 6.28% 5.51% 4.12% 3.92% 1.03%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - 13.68% 10.43%
Cost of Revenue to Revenue
20.19% 19.72% 20.47% 13.02% 13.11% 13.16% 14.57% 17.62% 19.48% 21.52% 1.29%
SG&A Expenses to Revenue
3.12% 3.10% 3.26% 3.20% 3.02% 3.10% 3.10% 3.16% 2.92% 2.79% 2.40%
R&D to Revenue
15.62% 16.28% 15.45% 15.25% 15.53% 16.12% 17.01% 17.26% 16.83% 17.18% 15.25%
Operating Expenses to Revenue
45.79% 46.11% 45.85% 52.72% 51.32% 49.26% 59.68% 56.17% 51.53% 47.68% 68.12%
Earnings before Interest and Taxes (EBIT)
12,909 13,478 14,449 14,350 14,058 15,495 10,404 12,631 15,255 17,738 24,153
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
15,418 15,929 17,234 17,269 17,026 18,411 13,526 18,739 21,394 23,912 33,447
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.09 3.09 3.72 7.30 13.15 41.26 0.00 262.05 36.90 22.70 17.29
Price to Tangible Book Value (P/TBV)
18.86 53.06 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
3.95 4.40 4.38 4.03 4.06 5.34 4.37 5.63 6.06 8.09 9.64
Price to Earnings (P/E)
16.44 17.60 48.12 14.35 15.67 15.72 27.60 33.07 30.69 37.30 38.23
Dividend Yield
1.70% 1.58% 1.80% 1.74% 1.91% 1.39% 1.84% 1.31% 1.37% 1.03% 0.89%
Earnings Yield
6.08% 5.68% 2.08% 6.97% 6.38% 6.36% 3.62% 3.02% 3.26% 2.68% 2.62%
Enterprise Value to Invested Capital (EV/IC)
3.79 3.44 4.14 4.37 4.56 5.83 4.98 4.42 4.66 5.34 5.35
Enterprise Value to Revenue (EV/Rev)
3.63 4.20 4.23 4.51 4.81 6.29 5.65 7.25 7.51 9.51 11.17
Enterprise Value to EBITDA (EV/EBITDA)
8.73 9.96 9.66 10.31 11.04 13.82 17.73 19.32 18.60 22.84 22.50
Enterprise Value to EBIT (EV/EBIT)
10.42 11.77 11.52 12.41 13.37 16.43 23.05 28.66 26.09 30.79 31.16
Enterprise Value to NOPAT (EV/NOPAT)
13.72 15.18 43.47 14.56 16.10 15.82 24.99 29.67 29.07 35.15 41.79
Enterprise Value to Operating Cash Flow (EV/OCF)
9.83 11.23 10.82 12.23 14.31 16.02 25.14 21.09 21.31 26.23 23.53
Enterprise Value to Free Cash Flow (EV/FCFF)
12.26 0.00 17.21 15.14 16.90 18.58 47.49 0.00 39.44 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.92 1.07 1.29 2.51 5.63 14.15 -13.15 58.15 9.40 4.41 3.01
Long-Term Debt to Equity
0.84 0.89 1.20 2.31 5.44 12.77 -12.50 55.54 8.25 4.07 2.84
Financial Leverage
-0.25 -0.20 -0.15 0.17 1.34 3.55 498.09 -31.87 14.50 5.22 2.80
Leverage Ratio
2.30 2.42 2.70 3.56 6.39 13.21 1,306.54 -57.85 25.51 10.24 6.72
Compound Leverage Factor
2.04 2.10 2.32 3.04 5.48 11.08 960.57 -41.80 19.63 8.17 5.44
Debt to Total Capital
47.85% 51.63% 56.39% 71.52% 84.92% 93.40% 108.23% 98.31% 90.39% 81.53% 75.05%
Short-Term Debt to Total Capital
4.09% 8.74% 4.18% 5.72% 2.81% 9.15% 5.35% 4.41% 11.03% 6.40% 4.17%
Long-Term Debt to Total Capital
43.76% 42.90% 52.22% 65.80% 82.11% 84.25% 102.88% 93.90% 79.35% 75.13% 70.88%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.87%
Noncontrolling Interests to Total Capital
0.55% 0.34% 0.47% 0.74% 0.76% 0.79% 0.64% 0.52% 0.56% 0.46% 0.32%
Common Equity to Total Capital
51.60% 48.02% 43.14% 27.74% 14.32% 5.81% -8.87% 1.17% 9.06% 18.01% 21.76%
Debt to EBITDA
2.84 3.64 3.52 3.25 4.21 4.58 5.61 4.83 4.06 3.87 3.87
Net Debt to EBITDA
-0.80 -0.51 -0.39 1.06 1.68 2.05 3.99 4.28 3.56 3.40 2.92
Long-Term Debt to EBITDA
2.60 3.02 3.26 2.99 4.07 4.13 5.33 4.61 3.56 3.57 3.66
Debt to NOPAT
4.47 5.54 15.83 4.59 6.13 5.24 7.91 7.42 6.35 5.96 7.19
Net Debt to NOPAT
-1.25 -0.78 -1.73 1.50 2.44 2.34 5.62 6.58 5.57 5.24 5.42
Long-Term Debt to NOPAT
4.09 4.60 14.66 4.23 5.93 4.72 7.52 7.08 5.57 5.49 6.79
Altman Z-Score
2.88 2.58 2.46 2.17 1.88 1.81 1.40 1.65 1.89 2.39 2.34
Noncontrolling Interest Sharing Ratio
0.97% 0.87% 0.88% 1.56% 3.48% 7.27% 633.70% -22.20% 9.43% 3.49% 9.40%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.74 3.08 3.98 2.49 3.03 2.30 1.62 0.91 0.72 0.75 1.12
Quick Ratio
3.57 2.95 3.79 2.31 2.83 2.15 1.43 0.74 0.59 0.61 1.01
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
10,973 -107 9,676 11,756 11,121 13,701 5,049 -21,462 10,090 -1,353 -20,363
Operating Cash Flow to CapEx
1,150.97% 698.96% 886.29% 876.57% 840.09% 744.12% 211.46% 197.41% 271.96% 98.14% 57.45%
Free Cash Flow to Firm to Interest Expense
7.48 -0.06 4.78 5.65 5.57 5.49 1.83 -6.12 2.87 -0.38 -4.43
Operating Cash Flow to Interest Expense
9.33 7.86 7.60 6.99 6.59 6.37 3.46 4.90 5.31 5.82 6.95
Operating Cash Flow Less CapEx to Interest Expense
8.52 6.73 6.74 6.19 5.80 5.51 1.83 2.42 3.36 -0.11 -5.15
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.33 0.31 0.29 0.32 0.35 0.33 0.35 0.41 0.38 0.37 0.31
Accounts Receivable Turnover
6.73 7.07 7.55 7.69 7.31 7.39 7.47 7.76 7.16 6.99 7.11
Inventory Turnover
28.44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
9.64 8.11 7.03 6.50 6.25 6.09 5.06 3.73 2.74 1.76 0.94
Accounts Payable Turnover
11.42 13.51 14.29 9.27 8.42 7.71 6.00 6.98 5.80 3.31 0.11
Days Sales Outstanding (DSO)
54.20 51.60 48.36 47.44 49.91 49.41 48.86 47.01 50.96 52.25 51.33
Days Inventory Outstanding (DIO)
12.84 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
31.97 27.01 25.54 39.36 43.36 47.36 60.84 52.26 62.99 110.38 3,382.98
Cash Conversion Cycle (CCC)
35.07 24.59 22.82 8.08 6.55 2.05 -11.98 -5.25 -12.02 -58.13 -3,331.65
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
35,520 46,077 40,231 40,703 41,257 43,643 48,189 81,850 85,447 102,334 140,703
Invested Capital Turnover
1.03 0.93 0.91 0.98 0.95 0.95 0.92 0.77 0.63 0.61 0.55
Increase / (Decrease) in Invested Capital
-1,168 10,557 -5,846 472 554 2,386 4,546 33,661 3,597 16,887 38,369
Enterprise Value (EV)
134,539 158,613 166,476 178,012 187,962 254,523 239,781 361,955 397,934 546,068 752,503
Market Capitalization
146,308 166,396 172,617 159,094 158,779 216,118 185,372 281,178 321,191 464,185 649,354
Book Value per Share
$11.40 $13.09 $11.36 $6.37 $3.83 $1.82 ($2.33) $0.40 $3.17 $7.29 $13.06
Tangible Book Value per Share
$1.87 $0.76 ($0.99) ($7.98) ($11.24) ($14.26) ($19.29) ($26.31) ($21.98) ($16.53) ($8.59)
Total Capital
91,645 112,155 107,492 78,530 84,314 90,197 70,091 92,037 96,108 113,537 172,597
Total Debt
43,855 57,909 60,619 56,167 71,597 84,245 75,859 90,481 86,869 92,568 129,541
Total Long-Term Debt
40,105 48,112 56,128 51,673 69,226 75,995 72,110 86,420 76,264 85,297 122,342
Net Debt
-12,270 -8,169 -6,642 18,340 28,540 37,691 53,957 80,294 76,208 81,365 97,647
Capital Expenditures (CapEx)
1,189 2,021 1,736 1,660 1,564 2,135 4,511 8,695 6,866 21,215 55,663
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-5,270 -5,944 -5,735 -5,577 -5,746 -6,901 -6,031 -8,212 -9,046 -11,996 -19,892
Debt-free Net Working Capital (DFNWC)
50,855 60,134 61,526 32,250 37,311 39,653 15,871 1,975 1,615 -793 12,002
Net Working Capital (NWC)
47,105 50,337 57,035 27,756 34,940 31,403 12,122 -2,086 -8,990 -8,064 4,803
Net Nonoperating Expense (NNE)
904 998 243 1,145 1,540 2,341 2,878 3,696 3,220 3,091 919
Net Nonoperating Obligations (NNO)
-12,270 -8,169 -6,642 18,340 28,540 37,691 53,957 80,294 76,208 81,365 97,647
Total Depreciation and Amortization (D&A)
2,509 2,451 2,785 2,919 2,968 2,916 3,122 6,108 6,139 6,174 9,294
Debt-free, Cash-free Net Working Capital to Revenue
-14.23% -15.73% -14.56% -14.12% -14.71% -17.05% -14.21% -16.44% -17.08% -20.90% -29.53%
Debt-free Net Working Capital to Revenue
137.27% 159.12% 156.22% 81.63% 95.50% 97.96% 37.40% 3.95% 3.05% -1.38% 17.82%
Net Working Capital to Revenue
127.15% 133.19% 144.82% 70.26% 89.43% 77.58% 28.56% -4.18% -16.97% -14.05% 7.13%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.11 $2.27 $0.93 $3.05 $3.16 $4.67 $2.49 $3.15 $3.82 $4.46 $5.94
Adjusted Weighted Average Basic Shares Outstanding
4.22B 4.12B 4.12B 3.63B 3.21B 2.95B 2.70B 2.70B 2.74B 2.79B 2.86B
Adjusted Diluted Earnings per Share
$2.07 $2.21 $0.90 $2.97 $3.08 $4.55 $2.41 $3.07 $3.71 $4.34 $5.83
Adjusted Weighted Average Diluted Shares Outstanding
4.31B 4.22B 4.24B 3.73B 3.29B 3.02B 2.79B 2.77B 2.82B 2.87B 2.91B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $3.16 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
4.12B 4.14B 3.98B 3.34B 3.07B 2.79B 2.66B 2.71B 2.76B 2.81B 2.88B
Normalized Net Operating Profit after Tax (NOPAT)
10,194 10,908 9,733 12,668 11,932 11,047 13,901 12,833 14,327 15,863 19,612
Normalized NOPAT Margin
27.52% 28.86% 24.71% 32.06% 30.54% 27.29% 32.75% 25.69% 27.05% 27.64% 29.12%
Pre Tax Income Margin
30.89% 30.91% 31.55% 31.05% 30.88% 32.11% 18.02% 18.27% 22.17% 24.67% 29.03%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
8.80 7.50 7.14 6.89 7.05 6.21 3.78 3.60 4.34 4.96 5.25
NOPAT to Interest Expense
6.68 5.81 1.89 5.87 5.85 6.45 3.48 3.48 3.90 4.34 3.92
EBIT Less CapEx to Interest Expense
7.99 6.37 6.28 6.10 6.26 5.35 2.14 1.12 2.39 -0.97 -6.85
NOPAT Less CapEx to Interest Expense
5.87 4.69 1.03 5.08 5.07 5.59 1.85 1.00 1.94 -1.59 -8.19
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
29.50% 27.84% 87.54% 26.45% 30.29% 22.28% 51.47% 43.14% 41.95% 38.12% 33.87%
Augmented Payout Ratio
146.79% 65.51% 403.88% 352.54% 220.13% 174.57% 293.36% 58.43% 53.43% 42.94% 34.42%

Quarterly Metrics And Ratios for Oracle

This table displays calculated financial ratios and metrics derived from Oracle's official financial filings.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 5/31/2025 8/31/2025 11/30/2025 2/28/2026 5/31/2026 8/31/2026
DEI Shares Outstanding
- - - - - - - - 2,873,130,000.00 2,876,046,000.00 2,880,471,000.00
DEI Adjusted Shares Outstanding
- - - - - - - - 2,873,130,000.00 2,876,046,000.00 2,880,471,000.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 1.29 1.47 1.62
Growth Metrics
- - - - - - - - - - -
Revenue Growth
7.11% 3.26% 6.86% 8.64% 6.40% 11.31% 12.17% 14.22% - 20.63% 29.61%
EBITDA Growth
13.11% 10.00% 15.18% 11.51% 11.19% 9.88% 12.54% 65.23% - 41.42% 69.79%
EBIT Growth
19.67% 14.70% 23.53% 17.96% 16.01% 10.13% 8.45% 73.85% - 32.68% 61.72%
NOPAT Growth
12.77% -11.86% 9.83% 17.68% 18.08% 8.25% -0.97% 16.68% - 16.64% 56.36%
Net Income Growth
26.64% -5.27% 21.03% 25.89% 22.28% 9.04% -0.07% 94.70% - 25.59% 62.62%
EPS Growth
25.00% -7.50% 19.77% 23.60% 20.00% 7.21% -1.94% 90.91% - 21.85% 54.46%
Operating Cash Flow Growth
28.07% 7.69% 6.50% 811.89% 8.37% 1.25% 9.60% 58.44% - 137.45% 183.82%
Free Cash Flow Firm Growth
100.05% 101.02% -3.68% -133.13% -52,895.12% -4,359.77% -1,007.56% -618.85% - -164.00% -172.15%
Invested Capital Growth
3.86% 4.39% 6.49% 8.37% 13.60% 19.76% 23.69% 29.73% - 37.49% 48.09%
Revenue Q/Q Growth
2.62% 7.58% -6.86% 5.65% 0.51% 12.55% -6.14% 7.58% - 11.59% 0.84%
EBITDA Q/Q Growth
2.65% 17.27% -12.46% 5.81% 2.36% 15.89% -10.34% 55.35% - 18.29% 7.64%
EBIT Q/Q Growth
3.69% 24.54% -13.91% 6.11% 1.97% 18.23% -15.22% 70.09% - 21.66% 3.33%
NOPAT Q/Q Growth
-5.71% 23.92% -5.28% 6.34% -5.39% 13.61% -13.35% 25.28% - 6.80% 16.16%
Net Income Q/Q Growth
-4.08% 30.90% -6.81% 7.58% -6.82% 16.72% -14.59% 109.60% - 15.67% 10.59%
EPS Q/Q Growth
-4.49% 30.59% -7.21% 6.80% -7.27% 16.67% -15.13% 107.92% - 14.17% 7.59%
Operating Cash Flow Q/Q Growth
3,728.67% 11.07% 22.13% -82.44% 354.98% 3.78% 32.21% -74.62% - 104.45% 58.02%
Free Cash Flow Firm Q/Q Growth
101.09% 1,927.66% -599.31% -112.05% -145.91% -63.60% -29.82% -37.63% - 2.20% -33.83%
Invested Capital Q/Q Growth
-0.26% 1.41% -0.67% 7.87% 4.55% 6.92% 2.58% 13.14% - 4.59% 10.49%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
79.90% 80.65% 79.27% 79.24% 78.21% 77.39% 98.81% 98.66% - 98.48% 60.03%
EBITDA Margin
39.89% 43.49% 40.87% 40.93% 41.69% 42.93% 41.01% 59.22% - 50.33% 53.72%
Operating Margin
28.24% 32.79% 29.99% 30.02% 30.84% 32.13% 28.65% 29.46% - 31.98% 34.78%
EBIT Margin
28.17% 32.61% 30.14% 30.27% 30.71% 32.26% 29.14% 46.08% - 35.49% 36.37%
Profit (Net Income) Margin
18.08% 22.00% 22.01% 22.41% 20.78% 21.55% 19.61% 38.21% - 22.44% 24.61%
Tax Burden Percent
83.80% 83.13% 92.43% 92.95% 85.15% 82.52% 85.41% 96.74% - 80.16% 84.89%
Interest Burden Percent
76.58% 81.15% 79.01% 79.65% 79.45% 80.94% 78.78% 85.71% - 78.86% 79.70%
Effective Tax Rate
16.20% 16.87% 7.57% 7.05% 14.85% 17.48% 14.59% 3.26% - 19.84% 15.11%
Return on Invested Capital (ROIC)
15.03% 17.26% 18.13% 17.41% 16.28% 16.21% 15.22% 16.54% - 14.21% 16.27%
ROIC Less NNEP Spread (ROIC-NNEP)
14.11% 16.30% 17.12% 16.43% 15.29% 15.21% 14.27% 18.42% - 13.52% 15.15%
Return on Net Nonoperating Assets (RNNOA)
532.26% 236.29% 182.55% 138.97% 102.09% 79.31% 61.13% 68.26% - 37.81% 27.79%
Return on Equity (ROE)
547.29% 253.54% 200.68% 156.39% 118.37% 95.52% 76.35% 84.79% - 52.02% 44.07%
Cash Return on Invested Capital (CROIC)
13.43% 12.06% 10.79% 8.61% 4.18% -1.44% -4.85% -10.28% - -16.76% -23.35%
Operating Return on Assets (OROA)
11.01% 12.54% 11.55% 11.76% 11.48% 11.97% 10.60% 15.91% - 11.12% 10.79%
Return on Assets (ROA)
7.07% 8.46% 8.43% 8.71% 7.77% 8.00% 7.13% 13.19% - 7.03% 7.30%
Return on Common Equity (ROCE)
410.40% 229.63% 187.54% 147.97% 112.87% 92.19% 74.30% 82.90% - 47.13% 41.24%
Return on Equity Simple (ROE_SIMPLE)
189.26% 0.00% 101.48% 84.56% 72.68% 0.00% 0.00% 0.00% - 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
3,143 3,894 3,689 3,922 3,711 4,216 3,653 4,577 4,604 4,917 5,712
NOPAT Margin
23.66% 27.26% 27.72% 27.90% 26.26% 26.51% 24.47% 28.50% - 25.63% 29.53%
Net Nonoperating Expense Percent (NNEP)
0.92% 0.96% 1.01% 0.98% 0.99% 1.00% 0.94% -1.88% - 0.69% 1.13%
Return On Investment Capital (ROIC_SIMPLE)
- - - 3.81% 3.27% 3.71% 3.15% 3.30% 2.65% 2.85% 2.97%
Cost of Revenue to Revenue
20.10% 19.35% 20.73% 20.76% 21.79% 22.61% 1.19% 1.34% - 1.52% 39.97%
SG&A Expenses to Revenue
2.84% 2.82% 2.69% 2.75% 2.76% 2.94% 2.52% 2.55% - 2.31% 1.94%
R&D to Revenue
16.93% 15.57% 17.33% 17.58% 17.19% 16.69% 16.69% 15.95% - 13.62% 12.41%
Operating Expenses to Revenue
51.66% 47.86% 49.27% 49.23% 47.37% 45.27% 70.15% 69.20% - 66.50% 25.25%
Earnings before Interest and Taxes (EBIT)
3,741 4,659 4,011 4,256 4,340 5,131 4,350 7,399 5,596 6,808 7,035
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
5,298 6,213 5,439 5,755 5,891 6,827 6,121 9,509 8,162 9,655 10,393
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
54.27 36.90 36.00 37.26 27.76 22.70 26.30 19.16 - 17.29 6.95
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Price to Revenue (P/Rev)
5.81 6.06 7.24 9.32 8.33 8.09 10.76 9.41 - 9.64 5.98
Price to Earnings (P/E)
28.67 30.69 35.48 44.06 38.20 37.30 51.05 37.20 - 38.23 22.93
Dividend Yield
1.44% 1.37% 1.13% 0.87% 0.96% 1.03% 0.80% 0.94% - 0.89% 1.34%
Earnings Yield
3.49% 3.26% 2.82% 2.27% 2.62% 2.68% 1.96% 2.69% - 2.62% 4.36%
Enterprise Value to Invested Capital (EV/IC)
4.55 4.66 5.46 6.44 5.68 5.34 6.82 5.58 - 5.35 3.37
Enterprise Value to Revenue (EV/Rev)
7.31 7.51 8.61 10.74 9.74 9.51 12.13 10.86 - 11.17 7.29
Enterprise Value to EBITDA (EV/EBITDA)
18.43 18.60 20.96 25.99 23.33 22.84 29.11 23.38 - 22.50 13.87
Enterprise Value to EBIT (EV/EBIT)
26.18 26.09 28.93 35.40 31.48 30.79 39.61 31.23 - 31.16 19.49
Enterprise Value to NOPAT (EV/NOPAT)
26.96 29.07 32.98 40.26 35.72 35.15 46.19 40.39 - 41.79 26.07
Enterprise Value to Operating Cash Flow (EV/OCF)
21.04 21.31 24.23 29.08 26.20 26.23 33.25 29.72 - 23.53 11.15
Enterprise Value to Free Cash Flow (EV/FCFF)
34.55 39.44 52.20 77.82 144.55 0.00 0.00 0.00 - 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
14.23 9.40 7.50 6.23 5.58 4.41 3.70 3.55 - 3.01 1.87
Long-Term Debt to Equity
13.34 8.25 6.68 5.65 5.10 4.07 3.33 3.28 - 2.84 1.75
Financial Leverage
37.73 14.50 10.66 8.46 6.68 5.22 4.28 3.71 - 2.80 1.84
Leverage Ratio
62.93 25.51 19.91 15.19 12.73 10.24 9.03 7.91 - 6.72 5.27
Compound Leverage Factor
48.19 20.70 15.73 12.10 10.11 8.29 7.12 6.78 - 5.30 4.20
Debt to Total Capital
93.43% 90.39% 88.24% 86.16% 84.80% 81.53% 78.73% 78.01% - 75.05% 65.10%
Short-Term Debt to Total Capital
5.85% 11.03% 9.61% 7.94% 7.19% 6.40% 7.83% 5.84% - 4.17% 3.96%
Long-Term Debt to Total Capital
87.58% 79.35% 78.63% 78.22% 77.60% 75.13% 70.90% 72.17% - 70.88% 61.14%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 2.87% 2.57%
Noncontrolling Interests to Total Capital
0.59% 0.56% 0.47% 0.48% 0.47% 0.46% 0.44% 0.37% - 0.32% 0.22%
Common Equity to Total Capital
5.97% 9.06% 11.29% 13.36% 14.74% 18.01% 20.83% 21.62% - 21.76% 32.11%
Debt to EBITDA
4.22 4.06 3.82 3.90 4.13 3.87 3.71 3.81 - 3.87 3.32
Net Debt to EBITDA
3.75 3.56 3.33 3.41 3.37 3.40 3.27 3.12 - 2.92 2.34
Long-Term Debt to EBITDA
3.96 3.56 3.41 3.54 3.78 3.57 3.34 3.53 - 3.66 3.12
Debt to NOPAT
6.18 6.35 6.01 6.05 6.33 5.96 5.89 6.59 - 7.19 6.24
Net Debt to NOPAT
5.48 5.57 5.24 5.28 5.16 5.24 5.18 5.38 - 5.42 4.40
Long-Term Debt to NOPAT
5.79 5.57 5.36 5.49 5.79 5.49 5.31 6.09 - 6.79 5.86
Altman Z-Score
1.59 1.65 1.94 2.53 2.22 2.14 2.64 2.31 - 2.12 1.43
Noncontrolling Interest Sharing Ratio
25.01% 9.43% 6.55% 5.38% 4.65% 3.49% 2.69% 2.23% - 9.40% 6.41%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.85 0.72 0.72 0.81 1.02 0.75 0.62 0.91 - 1.12 1.17
Quick Ratio
0.69 0.59 0.59 0.67 0.87 0.61 0.50 0.77 - 1.01 1.02
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
15 297 -1,485 -3,150 -7,745 -12,671 -16,450 -22,640 -34,206 -33,452 -44,768
Operating Cash Flow to CapEx
327.06% 217.33% 322.49% 32.85% 101.21% 67.81% 95.74% 17.17% - 88.64% 81.07%
Free Cash Flow to Firm to Interest Expense
0.02 0.34 -1.76 -3.64 -8.68 -12.96 -17.82 -21.42 - -23.25 -31.35
Operating Cash Flow to Interest Expense
6.25 6.93 8.82 1.51 6.65 6.30 8.82 1.95 - 10.16 16.18
Operating Cash Flow Less CapEx to Interest Expense
4.34 3.74 6.09 -3.08 0.08 -2.99 -0.39 -9.43 - -1.30 -3.78
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.39 0.38 0.38 0.39 0.37 0.37 0.36 0.35 - 0.31 0.30
Accounts Receivable Turnover
7.77 7.16 7.40 7.33 7.27 6.99 7.00 6.93 - 7.11 7.09
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Fixed Asset Turnover
2.96 2.74 2.64 2.47 2.18 1.76 1.55 1.29 - 0.94 0.79
Accounts Payable Turnover
6.10 5.80 6.59 5.87 5.65 3.31 2.38 1.94 - 0.11 2.69
Days Sales Outstanding (DSO)
46.95 50.96 49.31 49.77 50.21 52.25 52.15 52.69 - 51.33 51.46
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Days Payable Outstanding (DPO)
59.81 62.99 55.39 62.19 64.65 110.38 153.62 188.51 - 3,382.98 135.91
Cash Conversion Cycle (CCC)
-12.85 -12.02 -6.08 -12.42 -14.44 -58.13 -101.47 -135.82 - -3,331.65 -84.46
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
84,258 85,447 84,873 91,549 95,714 102,334 104,976 118,766 134,524 140,703 155,456
Invested Capital Turnover
0.64 0.63 0.65 0.62 0.62 0.61 0.62 0.58 - 0.55 0.55
Increase / (Decrease) in Invested Capital
3,128 3,597 5,174 7,072 11,456 16,887 20,103 27,217 38,810 38,369 50,480
Enterprise Value (EV)
383,785 397,934 463,432 589,989 543,447 546,068 715,983 662,699 - 752,503 523,174
Market Capitalization
305,150 321,191 389,375 512,186 464,463 464,185 635,161 573,884 - 649,354 429,536
Book Value per Share
$2.05 $3.17 $3.92 $4.96 $5.98 $7.29 $8.60 $10.54 $11.67 $13.06 $21.46
Tangible Book Value per Share
($23.36) ($21.98) ($20.94) ($19.54) ($18.08) ($16.53) ($15.03) ($12.67) ($11.27) ($8.59) ($0.16)
Total Capital
94,162 96,108 95,784 102,860 113,537 113,537 115,981 138,532 173,656 172,597 192,533
Total Debt
87,980 86,869 84,515 88,624 96,276 92,568 91,315 108,075 134,605 129,541 125,337
Total Long-Term Debt
82,470 76,264 75,314 80,462 88,109 85,297 82,236 99,984 124,718 122,342 117,712
Net Debt
78,076 76,208 73,604 77,313 78,453 81,365 80,310 88,309 95,473 97,647 88,260
Capital Expenditures (CapEx)
1,674 2,798 2,303 3,970 5,862 9,080 8,502 12,033 18,635 16,493 28,499
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-8,216 -9,046 -10,683 -8,698 -9,163 -11,996 -17,166 -15,104 -15,108 -19,892 -21,336
Debt-free Net Working Capital (DFNWC)
1,688 1,615 228 2,613 8,660 -793 -6,161 4,662 24,024 12,002 15,741
Net Working Capital (NWC)
-3,822 -8,990 -8,973 -5,549 493 -8,064 -15,240 -3,429 14,137 4,803 8,116
Net Nonoperating Expense (NNE)
742 751 760 771 775 789 726 -1,558 883 613 952
Net Nonoperating Obligations (NNO)
78,076 76,208 73,604 77,313 78,453 81,365 80,310 88,309 95,473 97,647 88,260
Total Depreciation and Amortization (D&A)
1,557 1,554 1,428 1,499 1,551 1,696 1,771 2,110 2,566 2,847 3,358
Debt-free, Cash-free Net Working Capital to Revenue
-15.65% -17.08% -19.85% -15.83% -16.43% -20.90% -29.09% -24.75% - -29.53% -29.73%
Debt-free Net Working Capital to Revenue
3.21% 3.05% 0.42% 4.76% 15.52% -1.38% -10.44% 7.64% - 17.82% 21.93%
Net Working Capital to Revenue
-7.28% -16.97% -16.67% -10.10% 0.88% -14.05% -25.82% -5.62% - 7.13% 11.31%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.87 $1.15 $1.06 $1.13 $1.05 $1.22 $1.04 $2.14 $1.29 $1.47 $1.58
Adjusted Weighted Average Basic Shares Outstanding
2.75B 2.74B 2.76B 2.79B 2.80B 2.79B 2.83B 2.86B 2.87B 2.86B 2.97B
Adjusted Diluted Earnings per Share
$0.85 $1.11 $1.03 $1.10 $1.02 $1.19 $1.01 $2.10 $1.27 $1.45 $1.56
Adjusted Weighted Average Diluted Shares Outstanding
2.82B 2.82B 2.85B 2.87B 2.87B 2.87B 2.91B 2.92B 2.91B 2.91B 3B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
2.75B 2.76B 2.77B 2.80B 2.80B 2.81B 2.84B 2.87B 2.88B 2.88B 3.02B
Normalized Net Operating Profit after Tax (NOPAT)
3,348 4,056 3,768 4,029 3,788 4,284 4,007 4,990 4,750 5,577 5,791
Normalized NOPAT Margin
25.21% 28.39% 28.32% 28.66% 26.81% 26.94% 26.85% 31.07% - 29.07% 29.94%
Pre Tax Income Margin
21.57% 26.46% 23.81% 24.11% 24.40% 26.11% 22.96% 39.49% - 27.99% 28.98%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
4.27 5.31 4.76 4.91 4.87 5.25 4.71 7.00 - 4.73 4.93
NOPAT to Interest Expense
3.59 4.44 4.38 4.53 4.16 4.31 3.96 4.33 - 3.42 4.00
EBIT Less CapEx to Interest Expense
2.36 2.12 2.03 0.33 -1.71 -4.04 -4.50 -4.38 - -6.73 -15.03
NOPAT Less CapEx to Interest Expense
1.68 1.25 1.65 -0.05 -2.41 -4.97 -5.25 -7.05 - -8.04 -15.96
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
41.07% 41.95% 40.11% 38.04% 36.53% 38.12% 40.62% 34.81% - 33.87% 31.39%
Augmented Payout Ratio
52.35% 53.43% 51.07% 45.80% 41.48% 42.94% 45.00% 37.37% - 34.42% 31.89%

Financials Breakdown Chart

Key Financial Trends

Oracle’s latest results show strong revenue and earnings momentum, but also a balance sheet that has become more leveraged as the company continues to invest heavily. Over the last several years, Oracle has delivered steady top-line growth, improving quarterly profitability, and consistently strong operating cash flow. At the same time, capital spending has risen sharply, debt has increased, and equity has moved lower, which makes the company’s growth story more capital-intensive than it used to be.

  • Revenue has accelerated meaningfully. Q4 2026 revenue reached $19.2 billion, up from $14.3 billion in Q4 2025 and well above roughly $11.8 billion in Q4 2022.
  • Profitability has improved year over year. Q4 2026 net income attributable to common shareholders was $4.2 billion, versus $3.4 billion in Q4 2025 and $3.1 billion in Q4 2024.
  • Operating income is expanding. Q4 2026 operating income totaled $6.1 billion, compared with $5.1 billion in Q4 2025 and $4.7 billion in Q4 2024.
  • Cash from operations remains strong. Oracle generated $14.6 billion in operating cash flow in Q4 2026, up from $6.2 billion in Q4 2025 and $6.1 billion in Q4 2024.
  • Gross profit remains very large relative to cost of revenue. Q4 2026 gross profit was $18.9 billion on just $292 million of cost of revenue, reflecting a highly profitable business mix.
  • Deferred revenue continues to support future visibility. Current deferred revenue was $9.9 billion in Q3 2026 and $9.4 billion in Q2 2026, indicating a sizable backlog of billings already collected or contracted.
  • EPS is moving higher, but share count remains elevated. Q4 2026 diluted EPS was $1.45, up from $1.19 in Q4 2025, though diluted shares outstanding were still about 2.9 billion.
  • Oracle is still spending heavily on growth infrastructure. Capital expenditures were $16.5 billion in Q4 2026 and $18.6 billion in Q3 2026, far above prior-year levels.
  • Debt has increased significantly. Long-term debt rose to $124.7 billion in Q3 2026 from $76.3 billion in Q4 2024 and $86.4 billion in Q4 2024, while short-term debt also remains meaningful.
  • Book equity has weakened. Total common equity fell to $33.5 billion in Q3 2026 from $37.8 billion in Q2 2026 and $8.7 billion in Q4 2024, reflecting the strain of debt-funded investment and distributions.

Looking at the trend over the last four years, Oracle has clearly shifted into a higher-growth, higher-investment phase. Revenue has moved from roughly $11.4 billion in Q1 2023 to $19.2 billion in Q4 2026, while quarterly net income has generally trended higher as well. However, that growth has come with much larger capital spending and a heavier debt load.

The most important takeaway for investors: Oracle’s operating performance looks healthy and improving, but the company’s financial flexibility is less pristine than it was a few years ago. If management can keep revenue growth and cash generation ahead of the rising investment burden, the strategy could continue to work well. If not, the balance sheet could become a bigger concern.

09/24/26 06:54 AM ETAI Generated. May Contain Errors.

Oracle Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Oracle's fiscal year ends in May. Their fiscal year 2026 ended on May 31, 2026.

Oracle's net income appears to be on an upward trend, with a most recent value of $17.09 billion in 2026, rising from $8.90 billion in 2016. The previous period was $12.44 billion in 2025. See where experts think Oracle is headed by visiting Oracle's forecast page.

Oracle's total operating income in 2026 was $20.61 billion, based on the following breakdown:
  • Total Gross Profit: $66.49 billion
  • Total Operating Expenses: $45.88 billion

Over the last 10 years, Oracle's total revenue changed from $37.05 billion in 2016 to $67.36 billion in 2026, a change of 81.8%.

Oracle's total liabilities were at $218.70 billion at the end of 2026, a 48.4% increase from 2025, and a 239.7% increase since 2016.

In the past 10 years, Oracle's cash and equivalents has ranged from $9.77 billion in 2023 to $37.24 billion in 2020, and is currently $31.29 billion as of their latest financial filing in 2026.

Over the last 10 years, Oracle's book value per share changed from 11.40 in 2016 to 13.06 in 2026, a change of 14.6%.



Financial statements for NYSE:ORCL last updated on 9/11/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners